Monoclonal Gammopathy in Autoimmune Diseases: Marker, Consequence, Pathogenetic Factor—Or Coincidence?

Suboptimal Response to Eculizumab in Renal‐Limited Thrombotic Microangiopathy Associated With Malignant Hypertension and Monoclonal Gammopathy: A Case Report
Wenjuan Lei, Tianli Shi, Man Xu +1
Clinical case reports1 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Cardiac Amyloidosis in Monoclonal Gammopathy of Undetermined Significance
Samuel Copen, Stephen Copen
Cureus25 Oct 2026Peer-reviewedCC BY 4.0Full textCardiovascular medicinePMCEurope PMC
Corticosteroids drive oral candidiasis by impairing type-17 immunity without inducing interferon-gammopathy
Ashira Lubkin, Abigail Fellows, Lucas dos Santos Dias +2
mBio7 Oct 2026Peer-reviewedPublisher termsFull textInfectious diseaseCrossref
Cellular Phenotypic Changes in Endometriosis: Pathogenetic Mechanisms and Therapeutic Implications.
Jingyi Zhang, Yiyun Bai, Sang Luo +2
International journal of women's health24 Oct 2026Peer-reviewedCC BY-NCFull textObstetrics, gynaecology & paediatricsEurope PMCPMC
MicroRNA cargo of extracellular vesicles as mediators of immune dysregulation in pediatric immune thrombocytopenia: from pathogenetic drivers to biomarkers.
Lucia Argenziano, Maria Maddalena Marrapodi, Giuseppe Di Feo +3
Frontiers in genetics12 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX

@article{anon2026monoclonal,
  title = {{Monoclonal Gammopathy in Autoimmune Diseases: Marker, Consequence, Pathogenetic Factor—Or Coincidence?}},
  journal = {Biomedicines},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13701428},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Monoclonal Gammopathy in Autoimmune Diseases: Marker, Consequence, Pathogenetic Factor—Or Coincidence?
PY  - 2026
DA  - 2026/10/01
JO  - Biomedicines
UR  - https://europepmc.org/article/PMC/PMC13701428
SN  - 2227-9059
ER  -

Related

Cite